Literature DB >> 2138936

Changes in brain dopaminergic indices induced by perinatal exposure to cannabinoids in rats.

F Rodriguez de Fonseca1, M Cebeira, M L Hernández, J A Ramos, J J Fernández-Ruiz.   

Abstract

Perinatal exposure to cannabinoid derivatives has been shown to produce effects on brain development. In this study, we evaluated the changes induced by maternal exposure to hashish crude extract (HCE) during gestation and lactation in several biochemical indices of dopamine activity in the striatum and the limbic forebrain of offspring. Studies were performed either during the HCE exposure or after drug withdrawal. Perinatal exposure to HCE reduced the number of striatal D1 binding sites in females and increased the L-3,4-dihydroxyphenylacetic acid/dopamine (DOPAC/DA) ratio, whereas an increase in the number of striatal D2 binding sites, with a reduction in their affinity, and a decrease in the activity of tyrosine hydroxylase (TH) were observed in males. The DOPAC/DA ratio was also increased in the limbic forebrain in HCE-exposed females, but there were no changes in binding site parameters. Most of these effects disappeared after cessation of cannabinoid treatment, but the decrease in striatal TH activity in males was maintained during drug withdrawal. Interestingly, the affinity of D2 receptors in the striatum of females, the number of striatal D1 receptors in males, and the limbic TH activity in males increased after the cessation of drug treatment. These results allow us to conclude that: (1) the effects of perinatal exposure to HCE were different depending on the sex and the specific brain area studied; and (2) most of the effects disappeared after cessation of cannabinoid treatment, although some new changes then appeared.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2138936     DOI: 10.1016/0165-3806(90)90280-c

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  7 in total

1.  Neuroimaging of prenatal drug exposure.

Authors:  Diana L Dow-Edwards; Helene Benveniste; Marylou Behnke; Emmalee S Bandstra; Lynn T Singer; Yasmin L Hurd; L R Stanford
Journal:  Neurotoxicol Teratol       Date:  2006 May-Jun       Impact factor: 3.763

2.  Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.

Authors:  A Bonnin; R de Miguel; J G Castro; J A Ramos; J J Fernandez-Ruiz
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

Review 3.  Behavioural consequences of maternal exposure to natural cannabinoids in rats.

Authors:  M Navarro; P Rubio; F R de Fonseca
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

4.  Sex-dimorphic psychomotor activation after perinatal exposure to (-)-delta 9-tetrahydrocannabinol. An ontogenic study in Wistar rats.

Authors:  M Navarro; P Rubio; F Rodríguez de Fonseca
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

5.  delta 9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens.

Authors:  A Bonnin; J J Fernández-Ruiz; M Martín; F Rodríguez de Fonseca; M L Hernández; J A Ramos
Journal:  J Neural Transm Gen Sect       Date:  1993

6.  Distribution of indoleamines and [3H]paroxetine binding in rat brain regions following acute or perinatal delta 9-tetrahydrocannabinol treatments.

Authors:  F Molina-Holgado; E Molina-Holgado; M L Leret; M I González; T A Reader
Journal:  Neurochem Res       Date:  1993-11       Impact factor: 3.996

7.  Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin.

Authors:  M L Hernández; J J Fernández-Ruiz; M Navarro; R de Miguel; M Cebeira; L Vaticón; J A Ramos
Journal:  J Neural Transm Gen Sect       Date:  1994
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.